We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
Reseach in Chronic Lymphocytic Leukaemia at the Clínic
Reading time: 1 min
Chronic lymphocytic leukaemia research is mostly carried out at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and the haematology area. Specifically, the following groups are involved:
Molecular pathology in lymphoid neoplasms
Experimental therapies in lymphoid neoplasms
The Clínic leads numerous international translational research projects (e.g. the genome sequencing project in LLC [ICGC-CLL], the Lymphoma/Molecular Leukaemia Profiling Project [LLMPP]) and more than 20 clinical trials with new drugs. The use of CAR T-cell therapy (T-cells with chimeric antigenic receptors) in the treatment of lymphomas and lymphoid leukaemias is also important, with it being one of the centres accredited nationwide for the use of such treatment, both at the academic and commercial level.
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Receive the latest updates related to this content.
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.